ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Sun Pharma gets DCGI nod for Wegovy-like weight loss drug, launch after Novo Nordisk's patent expiry
Sun Pharma has received DCGI approval to launch Noveltreat, a generic semaglutide injection for chronic weight management in India. This GLP-1 receptor agonist will be available after patent expiry, offering a crucial treatment option for India's growing o
Announcement as on 23 January 2026

Veeva Expands Partnership With Novo Nordisk Through Vault CRM Adoption
(RTTNews) - Veeva Systems Inc. (VEEV), a cloud software company, on Wednesday said Novo Nordisk's International Operations business unit has committed to use Veeva Vault CRM, expanding the companies' existing partnership.
Announcement as on 07 January 2026

HC seeks Novo Nordisk's reply on Natco plea to revoke patent
The Delhi High Court has asked Novo Nordisk to explain why its patent for the diabetes and weight loss drug semaglutide should not be cancelled. Natco Pharma filed the petition. Novo Nordisk's patent expires in March. This has sparked patent disputes as ot
Announcement as on 06 January 2026

Take a pill! Novo Nordisk's Wegovy gets US' nod as daily pill for obesity treatment
Novo Nordisk's popular weight-loss drug Wegovy is now available as a pill in the US. The US Food and Drug Administration has approved the oral form. This offers a convenient daily option for adults struggling with obesity. The pill is expected to launch in
Announcement as on 23 December 2025

Healthify eyes more weight-loss drugmaker tie-ups after Novo Nordisk pact
Healthify, a prominent player in the Indian health-tech sector, is stepping up its collaborations with firms specializing in weight-loss medications. Following a strategic partnership with Novo Nordisk's division in India, the company is excited to roll ou
Announcement as on 05 December 2025

Announcements by Novo Nordisk A/s first page | Next page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 49.14
  • 12Day Average: 51
  • 20Day Average: 55.3
  • 50Day Average: 53.31
  • 100Day Average: 53.01
  • 150Day Average: 54.55
  • 200Day Average: 58.29

NVO Indicators & signals

Indicator MACD (12,26,9)

51.08, 53.15, -1.09
Indicator MACD is in negative zone

Indicator ADX (14)

18.75, 24.44, 35.71
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
13 Fri Feb 2026 49.57 49.20 to 49.84 1.31% 0.37 times
12 Thu Feb 2026 48.93 48.12 to 50.07 0.39% 0.43 times
11 Wed Feb 2026 48.74 48.08 to 48.96 -0.75% 0.45 times
10 Tue Feb 2026 49.11 48.98 to 50.58 -0.53% 0.46 times
09 Mon Feb 2026 49.37 49.01 to 51.09 3.57% 1.11 times
06 Fri Feb 2026 47.67 44.00 to 47.74 9.99% 1 times
05 Thu Feb 2026 43.34 43.24 to 45.67 -8.16% 1.98 times
04 Wed Feb 2026 47.19 46.47 to 49.10 -6.2% 1.72 times
03 Tue Feb 2026 50.31 49.96 to 59.40 -14.69% 2.03 times
02 Mon Feb 2026 58.97 56.40 to 59.30 -0.77% 0.48 times
30 Fri Jan 2026 59.43 58.29 to 60.39 0.17% 0.33 times
29 Thu Jan 2026 59.33 58.80 to 60.53 -1.64% 0.42 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top